Skip to main content

Table 1 Predictors of death at five years for cervical cancer patients in Botswana who initiated curative chemoradiation treatment

From: Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana

Variable Univariate Multivariate
HR 95% CI HR 95% CI
HIV
 Uninfected Reference    
 Infected 1.101311 .6339304  1.913278 1.250879 .657968  2.378075
Stage
 IA IB Reference    
 IIA IIB 3.229473 .991521  10.51868 2.72587 .802824  9.255287
 IIIA IIIB IV 4.204608 1.255063  14.08593 3.747349 1.08663  12.9231
Age
 <40 Reference    
 40-59 1.225026 .6760837  2.219677 1.617596 .8523011  3.070061
 >60 1.445736 .6559022  3.186681 1.953187 .8017136  4.758482
Baseline Hb
 ≤10 Reference    
 >10 0.4893405 .292142  .8196497 0.4624402 .256955  .8322505
Chemo cycles
 1 2.442394 1.191725  5.005592 1.992836 .9455122  4.200256
 2 1.039553 .4325541  2.498349 0.7922305 .3125914  2.007826
 3 1.202074 .6371535  2.26787 1.269207 .659052  2.444246
 ≥4 Reference    
Final EQD2
 <75 Reference    
 ≥75 1.011468 .9875201  1.035996 1.01332 .9895877  1.037622